NCT00220337View on ClinicalTrials.gov

A Trial to Assess the Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Diabetic Neuropathy

PHASE3CompletedINTERVENTIONAL
Enrollment

371

Participants

Timeline

Start Date

December 21, 2004

Primary Completion Date

October 31, 2007

Study Completion Date

October 31, 2007

Conditions
Painful Diabetic Neuropathy
Interventions
DRUG

Lacosamide

Lacosamide film-coated tablets; two times per day; up to 400 mg/day for 2.75 years

Trial Locations (1)

Unknown

Monheim

Sponsors

Lead Sponsor

UCB Pharma
All Listed Sponsors
collaborator

SCHWARZ BIOSCIENCES GmbH - Part of UCB Group

UNKNOWN

lead

UCB Pharma

INDUSTRY